Endometrial, breast and liver safety of soy isoflavones plus Lactobacillus sporogenes in post-menopausal women

Gynecological Endocrinology

Volumn 29, Issue 3, 2013, Pages 209-212

  Colacurci, Nicola ^a   De Franciscis, Pasquale ^a   Atlante, Marco ^b   Mancino, Pasquale ^c   Monti, Marco ^c   Volpini, Giuseppe ^d   Benvenuti, Claudio ^e  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b REGINA APOSTOLORUM HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d ASL RMA Woman Health Centre S Anna   (Italy)

^e Medical Department   (Italy)

Author keywords

Endometrial thickness; Isoflavones; Lactobacillus; Mammographic density; Menopausal symptoms

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM; COLECALCIFEROL; GAMMA GLUTAMYLTRANSFERASE; ISOFLAVONE DERIVATIVE; PROBIOTIC AGENT;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BREAST PROTECTION; CONTROLLED STUDY; DRUG SAFETY; ENDOMETRIAL THICKNESS; ENDOMETRIUM PROTECTION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; LACTOBACILLUS; LACTOBACILLUS SPOROGENES; LIVER FUNCTION; LIVER PROTECTION; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSAL SYNDROME; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYMPTOM;

BREAST; BREAST NEOPLASMS; DIETARY SUPPLEMENTS; ENDOMETRIAL HYPERPLASIA; ENDOMETRIUM; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEPATIC INSUFFICIENCY; HOT FLASHES; HUMANS; ISOFLAVONES; LACTOBACILLUS; LIVER; MIDDLE AGED; POSTMENOPAUSE; PROBIOTICS; SEEDS; SEVERITY OF ILLNESS INDEX; SOYBEANS;

EID: 84874326940     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.738724     Document Type: Article

References (42)

1. North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010;17:242-255.
2. Gambacciani M. New HRT options for the treatment of menopausal symptoms and the maintenance of quality of life in postmenopausal women. Endocrine 2004;24:231-238. (Pubitemid 41271154)
3. Rabin DS, Cipparrone N, Linn ES, Moen M. Why menopausal women do not want to take hormone replacement therapy. Menopause 1999;6:61-67. (Pubitemid 29131761)
4. Panay N. Integrating phytoestrogens with prescription medicinesYa conservative clinical approach to vasomotor symptom management. Maturitas 2007;57:90-94. (Pubitemid 46602897)
5. Lethaby AE, Brown J, Marjoribanks J, Kronenberg F, Roberts H, Eden J. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2007;4:CD001395.
6. Messina M. Investigating the optimal soy protein and isoflavone intakes for women: A perspective. Womens Health (Lond Engl) ;4:337-356.
7. Setchell KD, Cassidy A. Dietary isoflavones: Biological effects and relevance to human health. J Nutr 1999;129:758SY767S.
8. Pino AM, Valladares LE, Palma MA, Mancilla AM, Yáñez M, Albala C. Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women. J Clin Endocrinol Metab 2000;85:2797-2800. (Pubitemid 32269154)
9. Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 1986;58:2363-2371. (Pubitemid 17191592)
10. Sirtori CR. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Saf 2001;24:665-682. (Pubitemid 32758568)
11. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. Endometrial effects of long-term treatment with phytoestrogens: A randomized, double-blind, placebo-controlled study. Fertil Steril 2004;82:145-8, quiz 265. (Pubitemid 38968790)
12. Palacios S, Pornel B, Bergeron C, Chantre P, Nogales F, Aubert L, Vazquez F, et al. Endometrial safety assessment of a specific and standardized soy extract according to international guidelines. Menopause 2007;14:1006-1011. (Pubitemid 350098660)
13. Ju YH, Doerge DR, Allred KF, Allred CD, Helferich WG. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res 2002;62:2474-2477. (Pubitemid 34462720)
14. Ju YH, Doerge DR, Woodling KA, Hartman JA, Kwak J, Helferich WG. Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis 2008;29:2162-2168.
15. Izumi T, Piskula MK, Osawa S, Obata A, Tobe K, Saito M, Kataoka S, et al. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr 2000;130:1695-1699. (Pubitemid 30451055)
16. Borriello SP, Setchell KD, Axelson M, Lawson AM. Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol 1985;58:37-43. (Pubitemid 15136128)
17. Rekha CR, Vijayalakshmi G. Isoflavone phytoestrogens in soymilk fermented with ß-glucosidase producing probiotic lactic acid bacteria. Int J Food Sci Nutr 2011;62:111-120.
18. Ding WK, Shah NP. Enhancing the biotransformation of isoflavones in soymilk supplemented with lactose using probiotic bacteria during extended fermentation. J Food Sci 2010;75:M140-M149.
19. Colacurci N, Fornaro F, De Franciscis P, Palermo M, del Vecchio W. Effects of different types of hormone replacement therapy on mammographic density. Maturitas 2001;40:159-164. (Pubitemid 33079175)
20. Agosta C, Atlante M, Benvenuti C. Randomized controlled study on clinical efficacy of isoflavones plus Lactobacillus sporogenes, associated or not with a natural anxiolytic agent in menopause. Minerva Ginecol 2011;63:11-17.
21. Mucci M, Carraro C, Mancino P, Monti M, Papadia LS, Volpini G, Benvenuti C. Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause. Minerva Ginecol 2006;58:323-334. (Pubitemid 44476708)
22. Benvenuti C, Setnikar I. Effect of Lactobacillus sporogenes on oral isoflavones bioavailability: Single dose pharmacokinetic study in menopausal women. Arzneimittelforschung 2011;61:605-609.
23. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of estrogens. N Engl J Med 2002;346:340-352.
24. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-4263. (Pubitemid 28513713)
25. Xu WH, Zheng W, Xiang YB, Ruan ZX, Cheng JR, Dai Q, Gao YT, Shu XO. Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: Population based case-control study. BMJ 2004;328:1285.
26. Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 1997;146:294-306. (Pubitemid 27355565)
27. Messina M, McCaskill-Stevens W, Lampe JW. Addressing the soy and breast cancer relationship: Review, commentary, and workshop proceedings. J Natl Cancer Inst 2006;98:1275-1284. (Pubitemid 44530723)
28. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006;98:459-471.
29. Nakamura Y, Tsuji S, Tonogai Y. Determination of the levels of isoflavonoids in soybeans and soy-derived foods and estimation of isoflavonoids in the Japanese daily intake. J AOAC Int 2000;83:635-650.
30. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008;98:9-14.
31. Kayisli UA, Aksu CA, Berkkanoglu M, Arici A. Estrogenicity of isoflavones on human endometrial stromal and glandular cells. J Clin Endocrinol Metab 2002;87:5539-5544. (Pubitemid 36034357)
32. Lian Z, Niwa K, Tagami K, Hashimoto M, Gao J, Yokoyama Y, Mori H, Tamaya T. Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice. Jpn J Cancer Res 2001;92:726-734. (Pubitemid 32747217)
33. Murray MJ, Meyer WR, Lessey BA, Oi RH, DeWire RE, Fritz MA. Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: A pilot trial. Menopause 2003;10:456-464.
34. Adlercreutz CH, Goldin BR, Gorbach SL, Höckerstedt KA, Watanabe S, Hämäläinen EK, Markkanen MH, et al. Soybean phytoestrogen intake and cancer risk. J Nutr 1995;125:757SY770S.
35. Messina M, Barnes S. The role of soy products in reducing risk of cancer. J Natl Cancer Inst 1991;83:541-546.
36. Santell RC, Kieu N, Helferich WG. Genistein inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice. J Nutr 2000;130:1665-1669. (Pubitemid 30451050)
37. Messina M. The endometrial effects of isoflavones: A discussion paper. Complement Ther Clin Pract 2008;14:212-214.
38. Foth D, Nawroth F. Effect of phytoestrogens on the endometrium? Fertil Steril 2005;83:256-7; author reply 257.
39. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1159-1169.
40. Hooper L, Madhavan G, Tice JA, Leinster SJ, Cassidy A. Effects of isoflavones on breast density in pre- and post-menopausal women: A systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update 2010;16:745-760.
41. Tempfer CB, Froese G, Heinze G, Bentz EK, Hefler LA, Huber JC. Side effects of phytoestrogens: A meta-analysis of randomized trials. Am J Med 2009;122:939-46.e9.
42. Consensus Opinion. The role of isoflavones in menopausal health: Consensus opinion of the North American Menopause Society. Menopause 2000;7:215-229.